Toxicity to the nervous system of diphenylhydantoin: a review.
D000305:Adrenal Cortex Hormones / Q000032:analysis; D000818:Animals; D002318:Cardiovascular Diseases / Q000139:chemically induced; D002524:Cerebellar Ataxia / Q000139:chemically induced; D002526:Cerebellar Diseases / Q000139:chemically induced / Q000473:pathology; D002531:Cerebellum / Q000473:pathology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005494:Folic Acid Deficiency / Q000139:chemically induced; D006801:Humans; D006944:Hyperglycemic Hyperosmolar Nonketotic Coma / Q000139:chemically induced; D001523:Mental Disorders / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D009422:Nervous System Diseases / Q000139:chemically induced*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D010672:Phenytoin / Q000009:adverse effects / Q000097:blood / Q000633:toxicity*; D012021:Reflex, Abnormal / Q000139:chemically induced; D012026:Reflex, Stretch; D012640:Seizures / Q000139:chemically induced; D013960:Thyroid Function Tests; D014277:Trigeminal Neuralgia / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D002556:Cerebrospinal Fluid Proteins; D010672:Phenytoin